Electrolab to launch online connectivity software
The Mumbai based Electrolab, manufacturer of dissolution tester for pharma industry in the country, will launch an online connectivity software next month.
The Mumbai based Electrolab, manufacturer of dissolution tester for pharma industry in the country, will launch an online connectivity software next month.
Indian drug maker Wockhardt recently acquired US-based speciality drugs company Morton Grove Pharmaceuticals, which has annual sales of $52 million.
Thermo Fisher Scientific Inc. , the world leader in serving science, today announced it has broken ground on a new USD 17 million facility in Ahmadabad, India, to support growing demand for biopharma services in that country.
Pharmaceuticals major Ranbaxy Laboratories plans to make China its major sourcing hub for active pharmaceutical ingredient (API).
Pfizer Inc and Sermo, the largest online physician community in the US, have announced a strategic collaboration designed to redefine the way physicians in the U.S. and the healthcare industry work together to improve patient care.
Quest Diagnostics announced recently that it has joined the National ePrescribing Patient Safety Initiative (NePSI), and will offer physicians access to its Care360 Physician Portal and results capabilities.
As pharma biggies like Ranbaxy and Dr Reddy
Mumbai-based Metropolis Health Services is in advanced talks to acquire a 60% stake in a London-based path lab chain.
Druggists and chemists across India have decided to get their fragmented retail business more organised in order to check the incresing presence of MNCs in the domestic market.
Sidney Taurel, CEO, Eli Lilly and Company called on the health care industry, medical community and U.S. government to work on a health information technology system to provide rapid and useful insights on the effectiveness of medicines while improving drug safety.
A clinical research firm Veeda Clinical Research Pvt. Ltd is proposing a project, wherein it will adopt about a dozen cancer hospitals in tier-II and tier-III cities across India to ensure easy access to a wider patient pool for its drug test projects.
After recently acquiring 100 per cent stake in the animal healthcare joint venture (JV) company